MNPR Earnings

Quarterly EPS
$-2.21
Q4 2024
$-0.38
Q1 2025
$-0.35
Q2 2025
$-0.48
Q3 2025
$-0.61
Q4 2025
$-0.46
Q1 2026
$-0.62
Q2 2026
$-0.72
Q3 2026
Latest RevenueN/A
Latest Net Income-6196475
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$0.720-6196475—-50.0%
Q2 2026-$0.620-5313300—-77.1%
Q1 2026-$0.460-3893050—-21.1%
Q4 2025-$0.610-5200794—+72.4%
Q3 2025-$0.480-3437601—-29.7%
Q2 2025-$0.350-2453526—+28.6%
Q1 2025-$0.380-2624972—+25.5%
Q4 2024-$2.210-10925608—-256.5%
Q3 2024-$0.370-1304276——
Q2 2024-$0.490-1715309——
Q1 2024-$0.510-1641226——
Q4 2023-$0.620-1813915——
Monopar Therapeutics (MNPR) — Earnings